2019 Official Proceedings
Total Page:16
File Type:pdf, Size:1020Kb
Scientific Session Awards Abstracts presented at the Society’s annual meeting will be considered for the following awards: The George Peters Award recognizes the best presentation by a breast fellow. In addition to a plaque, the winner receives $1,000. The winner is selected by the Society’s Publications Committee. The award was established in 2004 by the Society to honor Dr. George N. Peters, who was instrumental in bringing together the Susan G. Komen Breast Cancer Foundation, The American Society of Breast Surgeons, the American Society of Breast Disease, and the Society of Surgical Oncology to develop educational objectives for breast fellowships. The educational objectives were first used to award Komen Interdisciplinary Breast Fellowships. Subsequently the curriculum was used for the breast fellowship credentialing process that has led to the development of a nationwide matching program for breast fellowships. The Scientific Presentation Award recognizes an outstanding presentation by a resident, fellow, or trainee. The winner of this award is also determined by the Publications Committee. In addition to a plaque, the winner receives $500. All presenters are eligible for the Scientific Impact Award. The recipient of the award, selected by audience vote, is honored with a plaque. All awards are supported by The American Society of Breast Surgeons Foundation. 2 Publications Committee Chair Henry Kuerer, MD, PhD Vice-Chair Sarah Blair, MD Members Zahraa Al-Hilli, MD Katherina Zabicki Calvillo, MD Suzanne Brooks Coopey, MD David Danforth, MD Emilia Diego, MD Mehra Golshan, MD Marissa Howard-McNatt, MD Susan Kesmodel, MD Brigid Killelea, MD Michael Koretz, MD Swati A. Kulkarni, MD Holly Mason, MD Tracy-Ann Moo, MD May Lynn Quan, MD Miraj Shah-Khan, MD Elizabeth Shaughnessy, MD Jennifer Steiman, MD Preeti Subhedar, MD Julia Tchou, MD Mediget Teshome, MD Paul Thiruchelvam, MD Stephanie Valente, DO Kimberly Van Zee, MD Richard White, MD Katharine A. Yao, MD 3 This supplement was not sponsored by outside commercial interests. It was funded entirely by the publisher. 4 Contents Scientific Oral Presentations I ...................................................................................................... 18 581898 - Burnout and professional fulfillment in breast surgeons ....................................... 18 575089 - Patient selection for non-operative management of HER2+ invasive breast cancer after neoadjuvant systemic therapy ....................................................................................... 19 578685 - Perspectives on the costs of cancer care: A survey of the American Society of Breast Surgeons .................................................................................................................... 20 581304 - Interim analysis lymphedema “PREVENT” randomized trial .............................. 22 581545 - Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer ................................................ 23 581640 - Physician knowledge of contralateral breast cancer and local recurrence risk is associated with increased recommendations for contralateral prophylactic mastectomy: A survey of physicians at NAPBC-accredited centers ............................................................. 25 581645 - Implementation of post-mastectomy home recovery program in a large, integrated health delivery system........................................................................................................... 26 580940 - Reducing narcotic prescriptions in breast surgery patients: A prospective analysis ............................................................................................................................................... 27 581033 - A randomized prospective trial of supine MRI-guided vs wire localized lumpectomy for breast cancer ............................................................................................... 28 Scientific Oral Presentations II ..................................................................................................... 30 581296 - A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction ................................................................... 30 580579 - Outcomes of >1300 nipple-sparing mastectomies with immediate reconstruction: The impact of expanding indications on complications ....................................................... 31 580617 - DCIS with microinvasion: Is it in situ or invasive disease? .................................. 32 581702 - Evaluation of hormonal profile of breast cancer using 16 A- 18 F-Fluro-Estradiol PET CT: A novel technique .................................................................................................. 35 581360 - Sexual dysfunction in survivorship: The impact of menopause and endocrine therapy................................................................................................................................... 36 581366 - The role of loco-regional treatment in long-term quality of life in de novo Stage IV breast cancer patients: Protocol MF07-01Q .................................................................... 37 581963 - Is routine oncotype testing in patients over 70 years of age warranted? An evaluation of the National Cancer Database after TAILORx ............................................... 38 581969 - Same-day surgery for mastectomy patients in Alberta: A perioperative care pathway and quality improvement initiative......................................................................... 40 582345 - Neoadjuvant endocrine therapy vs chemotherapy in node-positive invasive lobular carcinoma .............................................................................................................................. 41 5 635483 - Preliminary results of a multi-center feasibility trial for real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins using the LUM Imaging System ................................................................................................................................... 43 Quickshot Presentations ................................................................................................................ 44 580281 - Provider perspective: Fertility preservation discussions in premenopausal breast cancer patients ....................................................................................................................... 44 580364 - Utility of second sentinel lymph node biopsy for patients with cN0 ipsilateral breast cancer recurrence after an initial sentinel lymph node biopsy ................................... 45 580844 - National patterns of nipple-sparing mastectomy for breast cancer, 2005-2015 .... 46 580928 - Distress: Characterizing what causes the thermometer to rise in patients with newly diagnosed breast cancer attending a multidisciplinary clinic ..................................... 46 562753 - Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: A National Cancer Database analysis .............................................. 47 581764 - Are we overtreating hormone receptor-positive breast cancer with neoadjuvant chemotherapy? Correlating OncotypeDx® results with tumor response in patients undergoing neoadjuvant chemotherapy ................................................................................ 49 581789 - Exploring surgeon variability in recommendations for contralateral prophylactic mastectomy: What matters most? ......................................................................................... 50 581830 - Value of sentinel lymph node biopsy for microinvasive breast cancer ................. 51 581837 - The 'Nipple Whipple'?! A pilot study to assess the ergonomic effects of nipple- sparing mastectomy .............................................................................................................. 52 582323 - p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression .................................................. 53 Poster Session I ............................................................................................................................. 54 Clinical Trials............................................................................................................................ 54 581643 - Interim analysis of the DCISionRT PREDICT Study: Clinical utility of a biologic signature predictive of radiation therapy benefit in patients with DCIS .............................. 54 581738 - Eliminating narcotic use with institutional enhanced recovery after surgery (ERAS) Protocol in autologous breast reconstruction patients following mastectomy: A pilot study.............................................................................................................................. 55 581918 - Radioactive iodine seed localization in axilla with sentinel node biopsy (RISAS): A prospective trial on axillary staging after neoadjuvant chemotherapy in node positive breast cancer.......................................................................................................................... 56 577360 - Pre-mastectomy radiotherapy feasibility trial to facilitate immediate autologous breast reconstruction: A prospective cohort